{
  "file_id": "file_cd64b05c2e6a",
  "source_path": "C:\\IntelliCV\\data\\resume_versions\\uploads\\61404 Reza Salimi\\Reza Salimi cv 61404.pdf",
  "extracted_at": "2025-08-10T16:27:21.480902",
  "text": " \n  \nREZA SALIMI  \nPROJECT MANAGER/ RESEARCH SCIENTIST/ SCIENTIFIC WRITER  \nImmunology , Oncology, Cardiovascular   \n \n \nCONTACT   \nPHONE:  \n+32 497 30 68 73  \nLinkedin:  \nhttps://www.linkedin.com/feed/  \nEMAIL:  \nrezasalimitr@yahoo.com  \n \nSOFT SKILLS   \n• Leader  \n• Team worker  \n• Problem solver  \n• Decision Maker  \n• Excellent communicator  \n• Well organized  \n \nKEY SUCCESS IN SCIENCE  \n•Establishment of multiple drug resistant cell \nlines (lung cancer)  \n• Establishment of cell lines using primary \ncells lung cancer  \n• Establishment of animal model , lung cancer, \nLymphedema and atherosclerosis  \n \nLANGUAGE SKILLS   \n• English (fluent)  \n• Azerbaij ani (maternal)  \n• Turkish (fluent)  \n• Persian (fluent)  \n• Dutch  (beginner )  \n• French (beginner)  \n  \nEDUCATION  \nDokuz Eylul Univer  \n  \nREZA SALIMI  \nPROJECT MANAGER/ RESEARCH SCIENTIST/ SCIENTIFIC WRITER  \nImmunology , Oncology, Cardiovascular   \n \n \nCONTACT   \nPHONE:  \n+32 497 30 68 73  \nLinkedin:  \nhttps://www.linkedin.com/feed/  \nEMAIL:  \nrezasalimitr@yahoo.com  \n \nSOFT SKILLS   \n• Leader  \n• Team worker  \n• Problem solver  \n• Decision Maker  \n• Excellent communicator  \n• Well organized  \n \nKEY SUCCESS IN SCIENCE  \n•Establishment of multiple drug resistant cell \nlines (lung cancer)  \n• Establishment of cell lines using primary \ncells lung cancer  \n• Establishment of animal model , lung cancer, \nLymphedema and atherosclerosis  \n \nLANGUAGE SKILLS   \n• English (fluent)  \n• Azerbaij ani (maternal)  \n• Turkish (fluent)  \n• Persian (fluent)  \n• Dutch  (beginner )  \n• French (beginner)  \n  \nEDUCATION  \nDokuz Eylul University, Izmir, Turkey                                                        2017 \nPh.D., Molecular Medicine GPA: 3. 23/4 \nDokuz Eylul University, Izmir, Turkey                                                       2013        \nMaster of Science, Molecular Medicine GPA: 3. 01/4 \nShahre -Qods Azad University, Tehran, Iran                                           2004  \nBachelor of Science, Cellular and Molecular Biology - Microbiology  \n \n \nWORK EXPERIENCE  \nEstablishing animal models and developing molecular biology \ntechniques and treatment, researcher                                2019–to Present  \nResearch & Development (R&D), and funding  projects  \nHuman Molecular Genetics, De Duve Institute, Université catholique de \nLouvain, Brussels, Belgium.  \n                         \nDrug and biomarker developer, researcher                            2017 -2018  \nLung cancer, Human brain cancer      \nIzmir Biomedicine & Genome Center (iBG - Izmir), Izmir, Turkey . \n \nEstablishing animal models and developing molecular biology \ntechniques and treatment, researcher                                    2014 -2017  \nInstitute of Biomedicine, University of Gothenburg, Gothe nburg, \nSweden . \n \n \n \n \n \n \n \n \n\n \n \n \n \n \n \n \n \nPUBLICATIONS  \n \n1. Bandaru S, Grönros J, Redfors B, Çil Ç, Pazooki D, Salimi R , Larsson E, Zhou AX, Ömerovic E, Akyürek  LM. Deficiency of filamin A in endothelial \ncells impairs left ventricular remodeling after myocardial infarction. Cardiovasc Res. 2015 Feb 1; 105(2):151 -9. \n \n2. Salimi R , Yener N, Safari R. Use and Evaluation of Newly Synthesized Fluorescence Probes to Detect  Generated OH• Radicals in Fibroblast \nCells. J Fluoresc. 2016 May; 26(3):919 -24. \n \n3. Safari R, Salimi R , Tunca Z, Ozerdem A, Ceylan D, Sakizli M. Mutation/SNP analysis in EF -hand calcium binding domain of mitochondrial \nCa+2 uptake 1 gene in bipolar disorder p atients. J Integr Neurosci. 2016 Jun; 15(2):163 -73. \n \n4. Babaie F, Hasankhani M, Mohammadi H, Safarzadeh E, Rezaiemanesh A, Salimi R , Baradaran B, babaloo  Z. The role of Gut Microbiota and \nIL-23/IL -17 Pathway in ankylosing spondylitis immunopathogenesis: new insights and updates. Immunology Letters. 2018 Apr; 196:52 -62. \n \n5. Salimi R , Bandaru S, Devarakonda S, Ala C, Alvandian A, Yener N, Akyürek LM. Blocking C leavage of Filamin A by Calpain Decreases Tumor \nCell Growth. Anticancer Res. 2018 Apr; 38(4):2079 -2085.  \n \n6. Bandaru S, Ala C, Salimi R , Akula MK, Ekstrand M, Devarakonda S, Karlsson J, Van den Eynden J, Bergström G, Larsson E, Levin M, Borén J, \nBergo MO, Akyü rek LM. Targeting Filamin A Reduces Macrophage Activity and Atherosclerosis. Circulation. 2019 Jul 2; 140(1):67 -79. \n \n7. Babaie F, Mohammadi H, Hemmatzadeh M, Ebrazeh M, Torkamandi S, Yousefi M, Hajaliloo M, Rezaiemanesh A, Salimi S, Salimi R , \nSafarzadeh E, Ba radaran B, Babaloo Z. Evaluation of ERAP1 gene single nucleotide polymorphisms in immunomodulation of pro -\ninflammatory and anti -inflammatory cytokines profile in ankylosing spondylitis. Immunol Lett. 2020 Jan; 217:31 -38. \nSKILLS  \n\n ",
  "emails": [
    "rezasalimitr@yahoo.com"
  ],
  "phones": [
    "+32 497 30 68"
  ],
  "names": [
    "Cardiovasc Res",
    "Newly Synthesized",
    "Decision Maker"
  ],
  "work_history": [],
  "skills": []
}